loadpatents
Patent applications and USPTO patent grants for Cerretti; Douglas Pat.The latest application filed is for "human c-fms antigen binding proteins".
Patent | Date |
---|---|
Human C-FMS antigen binding proteins Grant 9,988,457 - Brasel , et al. June 5, 2 | 2018-06-05 |
Human C-fms Antigen Binding Proteins App 20160340434 - BRASEL; Kenneth Allan ;   et al. | 2016-11-24 |
Human C-FMS antibodies Grant 9,303,084 - Brasel , et al. April 5, 2 | 2016-04-05 |
Human C-fms Antigen Binding Proteins App 20140105916 - BRASEL; Kenneth Allan ;   et al. | 2014-04-17 |
Methods for treating conditions associated with c-fms Grant 8,513,199 - Brasel , et al. August 20, 2 | 2013-08-20 |
Methods For Treating Conditions Associated With C-fms App 20120230987 - BRASEL; Kenneth Allan ;   et al. | 2012-09-13 |
Human C-FMS antigen binding proteins Grant 8,182,813 - Brasel , et al. May 22, 2 | 2012-05-22 |
Human C-fms Antigen Binding Proteins App 20090155164 - Brasel; Kenneth Allan ;   et al. | 2009-06-18 |
SVPH1-26 DNA and polypeptides App 20090017492 - Cerretti; Douglas Pat | 2009-01-15 |
ADAM20 (SVPH1-26) DNA and polypeptides App 20040053314 - Cerretti, Douglas Pat | 2004-03-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.